Maturity-onset diabetes of the young (MODY): how many cases are we missing?

By B. Shields, S. Hicks, M. Shepherd, K. Colclough, A. Hattersley, S. Ellard. Diabetologia, 2010

669 citations recorded by the source corpus.

Subfields: Endocrinology, Diabetes and Metabolism, Genetics, Surgery

View Paper: https://www.semanticscholar.org/paper/bb7f96a2641f55892c435ef29e94937aaf9d1dbc

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Genetics

1. Mike Tyers

Citations in the corpus

• 2. Classification and Diagnosis of Diabetes: Standards of Medical Care in Diabetes—2020 (2019, background): “For individuals with MODY, the treatment implications are considerable and warrant genetic testing (104,105).”
• Pathophysiology of diabetes: An overview (2020, background): “[14] These autoantibodies assume more clinical and diagnostic importance in some cases, particularly adults, with late-onset of this disease where the destruction of the pancreatic β-cells occurs at a very slow rate and often the disease masquerades as in T2DM.”
• The BioGRID interaction database: 2019 update (2018, background): “At present, 14 genes are genetically linked to various MODY subtypes and four of these genes (HNF1A, HNF4A, HNF1B and GCK) are known to account for >90% of MODY cases (49).”